Several lines of evidence support the hypothesis that abnormally elevated brain levels of kynurenic acid (KYNA), a metabolite of the kynurenine pathway (KP) of tryptophan degradation, play a pathophysiologically significant role in schizophrenia and other major neurodevelopmental disorders. Studies in experimental animal models suggest that KP impairments in these diseases may originate already in utero since prenatal administration of KYNA’s bioprecursor, kynurenine, leads to biochemical and structural abnormalities as well as distinct cognitive impairments in adulthood. As KP metabolism during pregnancy is still insufficiently understood, we designed this study to examine the de novo synthesis of KYNA and 3-hydroxykynurenine (3-HK), an alternative biologically active product of kynurenine degradation, in tissue slices obtained from pregnant mice on gestational day (GD) 18. Fetal brain and liver, placenta, and maternal brain and liver were collected, and the tissues were incubated in vitroin the absence or presence of micromolar concentrations of kynurenine. KYNA and 3-HK were measured in the extracellular milieu. Basal and newly produced KYNA was detected in all cases. As KYNA formation exceeded 3-HK production by 2–3 orders of magnitude in the placenta and maternal brain, and as very little 3-HK neosynthesis was detectable in fetal brain tissue, detailed follow-up experiments focused on KYNA only. The fetal brain produced 3–4 times more KYNA than the maternal brain and placenta, though less than the maternal and fetal liver. No significant differences were observed when using tissues obtained on GD 14 and GD 18. Pharmacological inhibition of KYNA’s main biosynthetic enzymes, kynurenine aminotransferase (KAT) I and KAT II, revealed qualitative and quantitative differences between the tissues, with a preferential role of KAT I in the fetal and maternal brain and of KAT II in the fetal and maternal liver. Findings using tissue slices from KAT II knockout mice confirmed these conclusions. Together, these results clarify the dynamics of KP metabolism during pregnancy and provide the basis for the conceptualization of interventions aimed at manipulating cerebral KP function in the prenatal period.

1.
Schwarcz
R
,
Bruno
JP
,
Muchowski
PJ
,
Wu
HQ
.
Kynurenines in the mammalian brain: when physiology meets pathology
.
Nat Rev Neurosci
.
2012
Jul
;
13
(
7
):
465
77
.
[PubMed]
1471-003X
2.
Badawy
AA
.
Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements
.
Neuropharmacology
.
2017
Jan
;
112
Pt B
:
248
63
.
[PubMed]
0028-3908
3.
Guidetti
P
,
Hoffman
GE
,
Melendez-Ferro
M
,
Albuquerque
EX
,
Schwarcz
R
.
Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry
.
Glia
.
2007
Jan
;
55
(
1
):
78
92
.
[PubMed]
0894-1491
4.
Han
Q
,
Cai
T
,
Tagle
DA
,
Li
J
.
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains
.
Cell Mol Life Sci
.
2010
Feb
;
67
(
3
):
353
68
.
[PubMed]
1420-682X
5.
Stone
TW
,
Stoy
N
,
Darlington
LG
.
An expanding range of targets for kynurenine metabolites of tryptophan
.
Trends Pharmacol Sci
.
2013
Feb
;
34
(
2
):
136
43
.
[PubMed]
0165-6147
6.
Moroni
F
,
Cozzi
A
,
Sili
M
,
Mannaioni
G
.
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
.
J Neural Transm (Vienna)
.
2012
Feb
;
119
(
2
):
133
9
.
[PubMed]
0300-9564
7.
Guidetti
P
,
Amori
L
,
Sapko
MT
,
Okuno
E
,
Schwarcz
R
.
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain
.
J Neurochem
.
2007
Jul
;
102
(
1
):
103
11
.
[PubMed]
0022-3042
8.
Turski
WA
,
Gramsbergen
JB
,
Traitler
H
,
Schwarcz
R
.
Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine
.
J Neurochem
.
1989
May
;
52
(
5
):
1629
36
.
[PubMed]
0022-3042
9.
Swartz
KJ
,
During
MJ
,
Freese
A
,
Beal
MF
.
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors
.
J Neurosci
.
1990
Sep
;
10
(
9
):
2965
73
.
[PubMed]
0270-6474
10.
Herédi
J
,
Cseh
EK
,
Berkó
AM
,
Veres
G
,
Zádori
D
,
Toldi
J
, et al.
Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations
.
Brain Res Bull
.
2019
Mar
;
146
:
185
91
.
[PubMed]
0361-9230
11.
Vécsei
L
,
Szalárdy
L
,
Fülöp
F
,
Toldi
J
.
Kynurenines in the CNS: recent advances and new questions
.
Nat Rev Drug Discov
.
2013
Jan
;
12
(
1
):
64
82
.
[PubMed]
1474-1776
12.
Heyes
MP
,
Saito
K
,
Crowley
JS
,
Davis
LE
,
Demitrack
MA
,
Der
M
, et al.
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
.
Brain
.
1992
Oct
;
115
(
Pt 5
):
1249
73
.
[PubMed]
0006-8950
13.
Oxenkrug
G
.
Serotonin-kynurenine hypothesis of depression: historical overview and recent developments
.
Curr Drug Targets
.
2013
May
;
14
(
5
):
514
21
.
[PubMed]
1389-4501
14.
Stone
TW
.
Kynurenines in the CNS: from endogenous obscurity to therapeutic importance
.
Prog Neurobiol
.
2001
Jun
;
64
(
2
):
185
218
.
[PubMed]
0301-0082
15.
Chen
Y
,
Guillemin
GJ
.
Kynurenine pathway metabolites in humans: disease and healthy States
.
Int J Tryptophan Res
.
2009
;
2
:
1
19
.
[PubMed]
1178-6469
16.
Schwarcz
R
,
Rassoulpour
A
,
Wu
HQ
,
Medoff
D
,
Tamminga
CA
,
Roberts
RC
.
Increased cortical kynurenate content in schizophrenia
.
Biol Psychiatry
.
2001
Oct
;
50
(
7
):
521
30
.
[PubMed]
0006-3223
17.
Erhardt
S
,
Blennow
K
,
Nordin
C
,
Skogh
E
,
Lindström
LH
,
Engberg
G
.
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
.
Neurosci Lett
.
2001
Nov
;
313
(
1-2
):
96
8
.
[PubMed]
0304-3940
18.
Linderholm
KR
,
Skogh
E
,
Olsson
SK
,
Dahl
ML
,
Holtze
M
,
Engberg
G
, et al.
Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia
.
Schizophr Bull
.
2012
May
;
38
(
3
):
426
32
.
[PubMed]
0586-7614
19.
Sathyasaikumar
KV
,
Stachowski
EK
,
Wonodi
I
,
Roberts
RC
,
Rassoulpour
A
,
McMahon
RP
, et al.
Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia
.
Schizophr Bull
.
2011
Nov
;
37
(
6
):
1147
56
.
[PubMed]
0586-7614
20.
Erhardt
S
,
Schwieler
L
,
Imbeault
S
,
Engberg
G
.
The kynurenine pathway in schizophrenia and bipolar disorder
.
Neuropharmacology
.
2017
Jan
;
112
Pt B
:
297
306
.
[PubMed]
0028-3908
21.
Pocivavsek
A
,
Notarangelo
FM
,
Wu
HQ
,
Bruno
JP
,
Schwarcz
R
.
Astrocytes as Pharmacological Targets in the Treatment of Schizophrenia: Focus on Kynurenic Acid. Modeling the Psychopathological Dimensions of Schizophrenia
.
San Diego, CA, USA
:
Elsevier
;
2016
. pp.
423
43
.
22.
Akagbosu
CO
,
Evans
GC
,
Gulick
D
,
Suckow
RF
,
Bucci
DJ
.
Exposure to kynurenic acid during adolescence produces memory deficits in adulthood
.
Schizophr Bull
.
2012
Jun
;
38
(
4
):
769
78
.
[PubMed]
0586-7614
23.
Asp
L
,
Holtze
M
,
Powell
SB
,
Karlsson
H
,
Erhardt
S
.
Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice
.
Int J Neuropsychopharmacol
.
2010
May
;
13
(
4
):
475
85
.
[PubMed]
1461-1457
24.
Erhardt
S
,
Pocivavsek
A
,
Repici
M
,
Liu
XC
,
Imbeault
S
,
Maddison
DC
, et al.
Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders
.
Biol Psychiatry
.
2017
Nov
;
82
(
10
):
756
65
.
[PubMed]
0006-3223
25.
DeAngeli
NE
,
Todd
TP
,
Chang
SE
,
Yeh
HH
,
Yeh
PW
,
Bucci
DJ
.
Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood
.
Front Behav Neurosci
.
2015
Jan
;
8
:
451
.
[PubMed]
1662-5153
26.
Pocivavsek
A
,
Thomas
MA
,
Elmer
GI
,
Bruno
JP
,
Schwarcz
R
.
Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats
.
Psychopharmacology (Berl)
.
2014
Jul
;
231
(
14
):
2799
809
.
[PubMed]
0033-3158
27.
Beal
MF
,
Swartz
KJ
,
Isacson
O
.
Developmental changes in brain kynurenic acid concentrations
.
Brain Res Dev Brain Res
.
1992
Jul
;
68
(
1
):
136
9
.
[PubMed]
0165-3806
28.
Ceresoli-Borroni
G
,
Schwarcz
R
.
Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain
.
Amino Acids
.
2000
;
19
(
1
):
311
23
.
[PubMed]
0939-4451
29.
Cannazza
G
,
Chiarugi
A
,
Parenti
C
,
Zanoli
P
,
Baraldi
M
.
Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development
.
Neurochem Res
.
2001
May
;
26
(
5
):
511
4
.
[PubMed]
0364-3190
30.
Notarangelo
FM
,
Pocivavsek
A
.
Elevated kynurenine pathway metabolism during neurodevelopment: implications for brain and behavior
.
Neuropharmacology
.
2017
Jan
;
112
Pt B
:
275
85
.
[PubMed]
0028-3908
31.
Walker
DW
,
Curtis
B
,
Lacey
B
,
Nitsos
I
.
Kynurenic acid in brain and cerebrospinal fluid of fetal, newborn, and adult sheep and effects of placental embolization
.
Pediatr Res
.
1999
Jun
;
45
(
6
):
820
6
.
[PubMed]
0031-3998
32.
Pershing
ML
,
Bortz
DM
,
Pocivavsek
A
,
Fredericks
PJ
,
Jørgensen
CV
,
Vunck
SA
, et al.
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia
.
Neuropharmacology
.
2015
Mar
;
90
:
33
41
.
[PubMed]
0028-3908
33.
Forrest
CM
,
Khalil
OS
,
Pisar
M
,
McNair
K
,
Kornisiuk
E
,
Snitcofsky
M
, et al.
Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway
.
Neuroscience
.
2013
Dec
;
254
:
241
59
.
[PubMed]
0306-4522
34.
Khalil
OS
,
Pisar
M
,
Forrest
CM
,
Vincenten
MC
,
Darlington
LG
,
Stone
TW
.
Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring
.
Eur J Neurosci
.
2014
May
;
39
(
10
):
1558
71
.
[PubMed]
0953-816X
35.
Pisar
M
,
Forrest
CM
,
Khalil
OS
,
McNair
K
,
Vincenten
MC
,
Qasem
S
, et al.
Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway
.
Brain Res
.
2014
Aug
;
1576
:
1
17
.
[PubMed]
0006-8993
36.
Pershing
ML
,
Phenis
D
,
Valentini
V
,
Pocivavsek
A
,
Lindquist
DH
,
Schwarcz
R
, et al.
Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding
.
Psychopharmacology (Berl)
.
2016
Oct
;
233
(
21-22
):
3725
35
.
[PubMed]
0033-3158
37.
Alexander
KS
,
Pocivavsek
A
,
Wu
HQ
,
Pershing
ML
,
Schwarcz
R
,
Bruno
JP
.
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine
.
Neuroscience
.
2013
May
;
238
:
19
28
.
[PubMed]
0306-4522
38.
Nilsen
RM
,
Bjørke-Monsen
AL
,
Midttun
O
,
Nygård
O
,
Pedersen
ER
,
Ulvik
A
, et al.
Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia
.
Obstet Gynecol
.
2012
Jun
;
119
(
6
):
1243
50
.
[PubMed]
0029-7844
39.
Goeden
N
,
Notarangelo
FM
,
Pocivavsek
A
,
Beggiato
S
,
Bonnin
A
,
Schwarcz
R
.
Prenatal dynamics of kynurenine pathway metabolism in mice: focus on kynurenic acid
.
Dev Neurosci
.
2017
;
39
(
6
):
519
28
.
[PubMed]
0378-5866
40.
Nicholls
T
,
Nitsos
I
,
Walker
DW
.
Tryptophan metabolism in pregnant sheep: increased fetal kynurenine production in response to maternal tryptophan loading
.
Am J Obstet Gynecol
.
1999
Dec
;
181
(
6
):
1452
60
.
[PubMed]
0002-9378
41.
Yu
P
,
Di Prospero
NA
,
Sapko
MT
,
Cai
T
,
Chen
A
,
Melendez-Ferro
M
, et al.
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice
.
Mol Cell Biol
.
2004
Aug
;
24
(
16
):
6919
30
.
[PubMed]
0270-7306
42.
Boisset
JC
,
Andrieu-Soler
C
,
van Cappellen
WA
,
Clapes
T
,
Robin
C
.
Ex vivo time-lapse confocal imaging of the mouse embryo aorta
.
Nat Protoc
.
2011
Oct
;
6
(
11
):
1792
805
.
[PubMed]
1754-2189
43.
Lowry
OH
,
Rosebrough
NJ
,
Farr
AL
,
Randall
RJ
.
Protein measurement with the Folin phenol reagent
.
J Biol Chem
.
1951
Nov
;
193
(
1
):
265
75
.
[PubMed]
0021-9258
44.
Notarangelo
FM
,
Schwarcz
R
.
Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain
.
Dev Neurosci
.
2016
;
38
(
6
):
458
68
.
[PubMed]
0378-5866
45.
Amori
L
,
Guidetti
P
,
Pellicciari
R
,
Kajii
Y
,
Schwarcz
R
.
On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo
.
J Neurochem
.
2009
Apr
;
109
(
2
):
316
25
.
[PubMed]
0022-3042
46.
Speciale
C
,
Wu
HQ
,
Gramsbergen
JB
,
Turski
WA
,
Ungerstedt
U
,
Schwarcz
R
.
Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid
.
Neurosci Lett
.
1990
Aug
;
116
(
1-2
):
198
203
.
[PubMed]
0304-3940
47.
Beggiato
S
,
Notarangelo
FM
,
Sathyasaikumar
KV
,
Giorgini
F
,
Schwarcz
R
.
Maternal genotype determines kynurenic acid levels in the fetal brain: implications for the pathophysiology of schizophrenia
.
J Psychopharmacol
.
2018
Nov
;
32
(
11
):
1223
32
.
[PubMed]
0269-8811
48.
Fukui
S
,
Schwarcz
R
,
Rapoport
SI
,
Takada
Y
,
Smith
QR
.
Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism
.
J Neurochem
.
1991
Jun
;
56
(
6
):
2007
17
.
[PubMed]
0022-3042
49.
Chrostowski
MK
,
McGonnigal
BG
,
Stabila
JP
,
Padbury
JF
.
LAT-1 expression in pre- and post-implantation embryos and placenta
.
Placenta
.
2009
Mar
;
30
(
3
):
270
6
.
[PubMed]
0143-4004
50.
Badawy
AA
.
Tryptophan metabolism, disposition and utilization in pregnancy
.
Biosci Rep
.
2015
Sep
;
35
(
5
):
35
.
[PubMed]
0144-8463
51.
Ligam
P
,
Manuelpillai
U
,
Wallace
EM
,
Walker
D
.
Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy
.
Placenta
.
2005
Jul
;
26
(
6
):
498
504
.
[PubMed]
0143-4004
52.
Manuelpillai
U
,
Ligam
P
,
Smythe
G
,
Wallace
EM
,
Hirst
J
,
Walker
DW
.
Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: up-regulation by inflammatory stimuli and with clinical infection
.
Am J Obstet Gynecol
.
2005
Jan
;
192
(
1
):
280
8
.
[PubMed]
0002-9378
53.
Alberati-Giani
D
,
Ricciardi-Castagnoli
P
,
Köhler
C
,
Cesura
AM
.
Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells
.
J Neurochem
.
1996
Mar
;
66
(
3
):
996
1004
.
[PubMed]
0022-3042
54.
Murthi
P
,
Wallace
EM
,
Walker
DW
.
Altered placental tryptophan metabolic pathway in human fetal growth restriction
.
Placenta
.
2017
Apr
;
52
:
62
70
.
[PubMed]
0143-4004
55.
Goasdoué
K
,
Miller
SM
,
Colditz
PB
,
Björkman
ST
.
Review: the blood-brain barrier; protecting the developing fetal brain
.
Placenta
.
2017
Jun
;
54
:
111
6
.
[PubMed]
0143-4004
56.
Notarangelo
FM
,
Wons
KS
,
Schwarcz
R
:
Prenatal LPS exposure preferentially increases kynurenine pathway metabolism in the fetal brain.
Society for Neuroscience Abstract
2015
;40:74.02.
57.
Nicholls
T
,
Nitsos
I
,
Smythe
G
,
Walker
DW
.
Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas
.
Am J Obstet Gynecol
.
2001
Oct
;
185
(
4
):
988
95
.
[PubMed]
0002-9378
58.
Sano
M
,
Ferchaud-Roucher
V
,
Kaeffer
B
,
Poupeau
G
,
Castellano
B
,
Darmaun
D
.
Maternal and fetal tryptophan metabolism in gestating rats: effects of intrauterine growth restriction
.
Amino Acids
.
2016
Jan
;
48
(
1
):
281
90
.
[PubMed]
0939-4451
59.
Baran
H
,
Kepplinger
B
,
Herrera-Marschitz
M
,
Stolze
K
,
Lubec
G
,
Nohl
H
.
Increased kynurenic acid in the brain after neonatal asphyxia
.
Life Sci
.
2001
Aug
;
69
(
11
):
1249
56
.
[PubMed]
0024-3205
60.
Ceresoli-Borroni
G
,
Schwarcz
R
.
Neonatal asphyxia in rats: acute effects on cerebral kynurenine metabolism
.
Pediatr Res
.
2001
Aug
;
50
(
2
):
231
5
.
[PubMed]
0031-3998
61.
Milart
P
,
Urbanska
EM
,
Turski
WA
,
Paszkowski
T
,
Sikorski
R
.
Kynurenine aminotransferase I activity in human placenta
.
Placenta
.
2001
Feb-Mar
;
22
(
2-3
):
259
61
.
[PubMed]
0143-4004
62.
Hodgkins
PS
,
Wu
HQ
,
Zielke
HR
,
Schwarcz
R
.
2-Oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo
.
J Neurochem
.
1999
Feb
;
72
(
2
):
643
51
.
[PubMed]
0022-3042
63.
Gramsbergen
JB
,
Hodgkins
PS
,
Rassoulpour
A
,
Turski
WA
,
Guidetti
P
,
Schwarcz
R
.
Brain-specific modulation of kynurenic acid synthesis in the rat
.
J Neurochem
.
1997
Jul
;
69
(
1
):
290
8
.
[PubMed]
0022-3042
64.
Schwarcz
R
,
Poeggeler
B
,
Rassoulpour
A
,
Ceresoli-Borroni
G
,
Hodgkins
PS
.
Regulation of kynurenic acid levels in the developing rat brain
.
Amino Acids
.
1998
;
14
(
1-3
):
243
9
.
[PubMed]
0939-4451
65.
Blanco Ayala
T
,
Lugo Huitrón
R
,
Carmona Aparicio
L
,
Ramírez Ortega
D
,
González Esquivel
D
,
Pedraza Chaverrí
J
, et al.
Alternative kynurenic acid synthesis routes studied in the rat cerebellum
.
Front Cell Neurosci
.
2015
May
;
9
:
178
.
[PubMed]
1662-5102
66.
Du
F
,
Schmidt
W
,
Okuno
E
,
Kido
R
,
Köhler
C
,
Schwarcz
R
.
Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus
.
J Comp Neurol
.
1992
Jul
;
321
(
3
):
477
87
.
[PubMed]
0021-9967
67.
Guillemin
GJ
,
Cullen
KM
,
Lim
CK
,
Smythe
GA
,
Garner
B
,
Kapoor
V
, et al.
Characterization of the kynurenine pathway in human neurons
.
J Neurosci
.
2007
Nov
;
27
(
47
):
12884
92
.
[PubMed]
0270-6474
68.
Herédi
J
,
Berkó
AM
,
Jankovics
F
,
Iwamori
T
,
Iwamori
N
,
Ono
E
, et al.
Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain
.
Brain Struct Funct
.
2017
May
;
222
(
4
):
1663
72
.
[PubMed]
1863-2653
69.
Roberts
RC
,
Du
F
,
McCarthy
KE
,
Okuno
E
,
Schwarcz
R
.
Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: a light and electron microscopic study
.
J Comp Neurol
.
1992
Dec
;
326
(
1
):
82
90
.
[PubMed]
0021-9967
70.
Bayraktar
OA
,
Fuentealba
LC
,
Alvarez-Buylla
A
,
Rowitch
DH
.
Astrocyte development and heterogeneity
.
Cold Spring Harb Perspect Biol
.
2014
Nov
;
7
(
1
):
a020362
.
[PubMed]
1943-0264
71.
Semple
BD
,
Blomgren
K
,
Gimlin
K
,
Ferriero
DM
,
Noble-Haeusslein
LJ
.
Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species
.
Prog Neurobiol
.
2013
Jul-Aug
;
106-107
:
1
16
.
[PubMed]
0301-0082
72.
Bagasrawala
I
,
Zecevic
N
,
Radonjić
NV
.
N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development
.
Front Neurosci
.
2016
Sep
;
10
:
435
.
[PubMed]
1662-4548
73.
Allen
NJ
,
Lyons
DA
.
Glia as architects of central nervous system formation and function
.
Science
.
2018
Oct
;
362
(
6411
):
181
5
.
[PubMed]
0036-8075
74.
Clark
DA
.
The use and misuse of animal analog models of human pregnancy disorders
.
J Reprod Immunol
.
2014
Jun
;
103
:
1
8
.
[PubMed]
0165-0378
75.
Boros
FA
,
Bohár
Z
,
Vécsei
L
.
Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases
.
Mutat Res
.
2018
Apr - Jun
;
776
:
32
45
.
[PubMed]
0027-5107
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.